According to the FDA, and other regulatory authorities, it is unlawful and illegal to promote an unapproved drug or biologic.
DCVax-L advertising, marketing and promotions will only happen after regulatory approvals. Most NWBO longs understand that it is in the best long-term interest of solid tumor cancer patients, and NWBio investors, for NWBio not to promote DCVax-L until after it is approved.
However, short sellers, and some manipulative Market Makers, and Hedge Funds, want NWBio to violate this requirement, and promote DCVax-L before it is approved, so they can use this to further attack the company and its stock.
Bullish